LevitasBio
PrivateLast Round
Series C
Nov 7, 2022
Total Funding Raised
$61M
Momentum Score
25 /100
Company Overview
LevitasBio is a life sciences and healthcare company that offers a revolutionary single-cell imaging and profiling platform for purifying cells and nuclei without the use of markers or modifications.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LevitasBio Comps
Public and private peers based on sector, stage, and business model.
LevitasBio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 7, 2022 | ||||
| Series B | Jan 5, 2021 | ||||
| Series A | Aug 3, 2017 |
Key People
Founding team and executive leadership
LevitasBio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Pavilion Capital | Series C |
| Novalis LifeSciences | Series C |
| Eos | Series C |
| Decheng Capital | Series C, Series B, Series A |
LevitasBio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LevitasBio's valuation, stock price, and market status.
